サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1291622

経口タンパク質・ペプチド市場：薬剤タイプ（リナクロチド、プレカナチド、カルシトニン、インスリン、オクトレオチド）、用途（胃・消化器系疾患、骨疾患、糖尿病、ホルモン疾患）、地域別2023-2028

Oral Proteins and Peptides Market by Drug Type (Linaclotide, Plecanatide, Calcitonin, Insulin, Octreotide), Application (Gastric and Digestive Disorders, Bone Diseases, Diabetes, Hormonal Disorders), and Region 2023-2028
出版日: | 発行: IMARC | ページ情報: 英文 143 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
経口タンパク質・ペプチド市場：薬剤タイプ（リナクロチド、プレカナチド、カルシトニン、インスリン、オクトレオチド）、用途（胃・消化器系疾患、骨疾患、糖尿病、ホルモン疾患）、地域別2023-2028
出版日: 2023年05月29日
発行: IMARC
ページ情報: 英文 143 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

市場概要：

世界の経口タンパク質・ペプチド市場規模は、2022年に15億7,000万米ドルに達しました。今後、IMARC Groupは、2023年から2028年の間に8.60%の成長率（CAGR）を示し、2028年までに26億7,000万米ドルに達すると予想しています。慢性疾患の蔓延、老年人口の増加、消費者の経口薬志向の高まりなどが、市場を牽引する重要な要因のひとつです。

経口タンパク質・ペプチドは人体の天然成分であり、多くの生物学的プロセスにおいて重要な役割を担っています。その複雑な構造と胃や小腸での消化のしにくさから、通常、注射で投与されます。しかし、経口タンパク質・ペプチドは、ホルモン、胃、代謝異常の治療のために、経口経路で摂取することができます。これらは、分子を消化から保護し、腸壁から血流に吸収されるようにする特殊な製剤を用いることで、これらの課題を克服するように設計されています。このような製剤には、腸溶性コーティング、ナノ粒子、その他の送達技術が含まれます。経口タンパク質・ペプチドは、糖尿病、がん、自己免疫疾患など、多くの慢性疾患の治療に広く利用されています。

経口タンパク質・ペプチドの市場動向：

がん、糖尿病、心血管障害、後天性免疫不全症候群（AIDs）などの慢性疾患を患う患者の増加と、老年人口の増加が、経口タンパク質・ペプチド市場の成長を促す主な要因となっています。このほか、嗜好の変化や、大衆の間で効果的な経口薬や技術に対する需要が高まっていることも、市場成長に寄与しています。さらに、消費者の健康意識の高まりと、経口タンパク質・ペプチドサプリメントの摂取に関連する数々の利点に対する認識の高まりが、市場に明るい展望を生み出しています。さらに、3Dプリンティング、ナノテクノロジー、遺伝子工学などの革新的な技術の進歩により、メーカーがより高度で費用対効果の高い製品バリエーションを製造できるようになり、これも大きな成長促進要因として作用しています。また、製薬会社間の幅広い協力関係、ヘルスケアインフラの大幅な進歩、研究開発活動の活発化も、市場に有益な成長機会をもたらしています。さらに、消費者の可処分所得の増加、タンパク質豊富な食生活の普及、プロテインパウダー、バー、シェイクの需要の急増、製品に簡単にアクセスできるオンラインプラットフォームの普及が、市場拡大の一助となっています。

本レポートで扱う主な質問

  • 世界の経口タンパク質・ペプチド市場はこれまでどのように推移し、今後数年間はどのように推移するのか？
  • 世界の経口タンパク質・ペプチド市場における促進要因、抑制要因、および機会は何か？
  • 各 促進要因、抑制要因、機会が世界の経口タンパク質・ペプチド市場に与える影響は？
  • 主要な地域市場とは？
  • 最も魅力的な経口タンパク質・ペプチド市場を代表する国はどこですか？
  • 薬剤の種類に基づく市場の内訳は？
  • 経口タンパク質・ペプチド市場において最も魅力的な薬剤タイプは何か？
  • アプリケーションに基づく市場の内訳は？
  • 経口タンパク質・ペプチド市場で最も魅力的なアプリケーションはどれか？
  • 世界の経口タンパク質・ペプチド市場の競争構造は？
  • 世界の経口タンパク質・ペプチド市場における主要なプレーヤー/企業はどこか？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 予測手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 世界の経口タンパク質・ペプチド市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 薬剤タイプ別市場内訳

  • リナクロチド
    • 市場動向
    • 市場予測
  • プレカナチド
    • 市場動向
    • 市場予測
  • カルシトニン
    • 市場動向
    • 市場予測
  • インスリン
    • 市場動向
    • 市場予測
  • オクトレオチド
    • 市場動向
    • 市場予測

第7章 用途別市場内訳

  • 胃・消化器系疾患
    • 市場動向
    • 市場予測
  • 骨疾患
    • 市場動向
    • 市場予測
  • 糖尿病
    • 市場動向
    • 市場予測
  • ホルモン疾患
    • 市場動向
    • 市場予測

第8章 地域別市場内訳

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋地域
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 国別市場内訳
    • 市場予測

第9章 促進要因・抑制要因・機会

  • 概要
  • 促進要因
  • 抑制要因
  • 機会

第10章 バリューチェーン分析

第11章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の度合い
  • 新規参入業者の脅威
  • 代替品の脅威

第12章 価格分析

第13章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Amryt Pharma Plc
    • AstraZeneca PLC
    • Biocon Limited
    • Novo Nordisk A/S
    • Oramed Ltd
    • Proxima Concepts Limited

本レポートに記載されている企業名は一部であり、全企業名は本レポートに記載されています。

図表

List of Figures

  • Figure 1: Global: Oral Proteins and Peptides Market: Major Drivers and Challenges
  • Figure 2: Global: Oral Proteins and Peptides Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Oral Proteins and Peptides Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Oral Proteins and Peptides Market: Breakup by Drug Type (in %), 2022
  • Figure 5: Global: Oral Proteins and Peptides Market: Breakup by Application (in %), 2022
  • Figure 6: Global: Oral Proteins and Peptides Market: Breakup by Region (in %), 2022
  • Figure 7: Global: Oral Proteins and Peptides (Linaclotide) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 8: Global: Oral Proteins and Peptides (Linaclotide) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 9: Global: Oral Proteins and Peptides (Plecanatide) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Oral Proteins and Peptides (Plecanatide) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Oral Proteins and Peptides (Calcitonin) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Oral Proteins and Peptides (Calcitonin) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Oral Proteins and Peptides (Insulin) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Oral Proteins and Peptides (Insulin) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Oral Proteins and Peptides (Octreotide) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Oral Proteins and Peptides (Octreotide) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Oral Proteins and Peptides (Gastric and Digestive Disorders) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Oral Proteins and Peptides (Gastric and Digestive Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Oral Proteins and Peptides (Bone Diseases) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Oral Proteins and Peptides (Bone Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Oral Proteins and Peptides (Diabetes) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Oral Proteins and Peptides (Diabetes) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Oral Proteins and Peptides (Hormonal Disorders) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Oral Proteins and Peptides (Hormonal Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: North America: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: North America: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: United States: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: United States: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Canada: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Canada: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Asia-Pacific: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Asia-Pacific: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: China: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: China: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Japan: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Japan: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: India: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: India: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: South Korea: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: South Korea: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: Australia: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: Australia: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: Indonesia: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: Indonesia: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: Others: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: Others: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: Europe: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: Europe: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: Germany: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: Germany: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: France: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: France: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: United Kingdom: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: United Kingdom: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: Italy: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Italy: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Spain: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Spain: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Russia: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Russia: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Others: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Others: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Latin America: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Latin America: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Brazil: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: Brazil: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: Mexico: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: Mexico: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: Others: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: Others: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Middle East and Africa: Oral Proteins and Peptides Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Middle East and Africa: Oral Proteins and Peptides Market: Breakup by Country (in %), 2022
  • Figure 73: Middle East and Africa: Oral Proteins and Peptides Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Global: Oral Proteins and Peptides Industry: Drivers, Restraints, and Opportunities
  • Figure 75: Global: Oral Proteins and Peptides Industry: Value Chain Analysis
  • Figure 76: Global: Oral Proteins and Peptides Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Oral Proteins and Peptides Market: Key Industry Highlights, 2022 & 2028
  • Table 2: Global: Oral Proteins and Peptides Market Forecast: Breakup by Drug Type (in Million US$), 2023-2028
  • Table 3: Global: Oral Proteins and Peptides Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 4: Global: Oral Proteins and Peptides Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 5: Global: Oral Proteins and Peptides Market: Competitive Structure
  • Table 6: Global: Oral Proteins and Peptides Market: Key Players
目次
Product Code: SR112023A7530

Market Overview:

The global oral proteins and peptides market size reached US$ 1.57 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.67 Billion by 2028, exhibiting a growth rate (CAGR) of 8.60% during 2023-2028. The expanding prevalence of chronic diseases, the rising geriatric population, and the increasing preference for oral drugs among consumers represent some of the key factors driving the market.

Proteins and peptides are natural components of the human body and play essential roles in many biological processes. Due to their complex structure and susceptibility to digestion in the stomach and small intestine, they are usually administered through injections. However, oral proteins and peptides can be taken via the oral path to treat hormonal, gastric, and metabolic disorders. They are designed to overcome these challenges by using specialized formulations that protect the molecules from digestion and allow them to be absorbed through the intestinal wall into the bloodstream. These formulations include enteric coatings, nanoparticles, and other delivery technologies. Oral proteins and peptides are extensively utilized to treat numerous chronic diseases, such as diabetes, cancer, and autoimmune disorders.

Oral Proteins and Peptides Market Trends:

The increasing volume of patients suffering from chronic diseases, such as cancer, diabetes, cardiovascular disorders (CVDs), and acquired immunodeficiency syndrome (AIDs), and the expanding geriatric population represent the key factors driving the oral proteins and peptides market growth. Besides this, shifting preferences and the rising demand for effective oral drugs and technology among the masses are contributing to the market growth. Moreover, the escalating consumer health consciousness and the growing awareness of the numerous benefits associated with the consumption of oral protein and peptide supplements are creating a positive outlook for the market. In addition to this, innovative technological advancements, such as three-dimensional (3D) printing, nanotechnology, and genetic engineering, have enabled manufacturers to produce more advanced and cost-effective product variants, which is acting as another significant growth-inducing factor. Concurrent with this, the extensive collaborative efforts between pharmaceutical companies, significant advancements in the healthcare infrastructure, and rising research and development (R&D) activities are presenting remunerative growth opportunities for the market. Furthermore, the inflating disposable income of consumers, the widespread adoption of protein-rich diets, the surging demand for protein powder, bars, and shakes, and the increasing proliferation of online platforms providing easy product access are aiding in market expansion.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global oral proteins and peptides market, along with forecasts at the global, regional, and country levels from 2023-2028. Our report has categorized the market based on drug type and application.

Drug Type Insights:

  • Linaclotide
  • Plecanatide
  • Calcitonin
  • Insulin
  • Octreotide

The report has provided a detailed breakup and analysis of the oral proteins and peptides market based on the drug type. This includes linaclotide, plecanatide, calcitonin, insulin, and octreotide. According to the report, insulin represented the largest segment.

Application Insights:

  • Gastric and Digestive Disorders
  • Bone Diseases
  • Diabetes
  • Hormonal Disorders

A detailed breakup and analysis of the oral proteins and peptides market based on the application has also been provided in the report. This includes gastric and digestive disorders, bone diseases, diabetes, and hormonal disorders. According to the report, diabetes accounted for the largest market share.

Regional Insights:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for oral proteins and peptides. Some of the factors driving the North America oral proteins and peptides market included the increasing prevalence of chronic diseases, the shifting consumer preference for oral drugs, and innovative product advancements.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global oral proteins and peptides market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Amryt Pharma Plc, AstraZeneca PLC, Biocon Limited, Novo Nordisk A/S, Oramed Ltd, Proxima Concepts Limited, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global oral proteins and peptides market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global oral proteins and peptides market?
  • What is the impact of each driver, restraint, and opportunity on the global oral proteins and peptides market?
  • What are the key regional markets?
  • Which countries represent the most attractive oral proteins and peptides market?
  • What is the breakup of the market based on the drug type?
  • Which is the most attractive drug type in the oral proteins and peptides market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the oral proteins and peptides market?
  • What is the competitive structure of the global oral proteins and peptides market?
  • Who are the key players/companies in the global oral proteins and peptides market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Oral Proteins and Peptides Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Drug Type

  • 6.1 Linaclotide
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Plecanatide
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Calcitonin
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Insulin
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Octreotide
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Gastric and Digestive Disorders
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Bone Diseases
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Diabetes
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Hormonal Disorders
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 Drivers, Restraints, and Opportunities

  • 9.1 Overview
  • 9.2 Drivers
  • 9.3 Restraints
  • 9.4 Opportunities

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Amryt Pharma Plc
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
    • 13.3.2 AstraZeneca PLC
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
      • 13.3.2.4 SWOT Analysis
    • 13.3.3 Biocon Limited
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 Novo Nordisk A/S
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
      • 13.3.4.4 SWOT Analysis
    • 13.3.5 Oramed Ltd
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
    • 13.3.6 Proxima Concepts Limited
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.